SGLT2 Inhibitor–Associated Bullous Pemphigoid: A Comprehensive Review of Clinical Phenotypes, Latency, Immunopathologic Findings, Proposed Mechanisms, and Clinical Outcomes
Manuscript Number2026/AJRDES/169331
Authors
Saud Abdullah Alsharif, Fahad Alrowais